Latest Revenue of Active Pharmaceutical Ingredients Market

Wilmington, Delaware, U.S., Oct. 13, 2022 (GLOBE NEWSWIRE) — Transparency Market Research Inc.The increasing adoption of advanced biopharmaceutical processes for synthetic APIs is a key strategy in the Active Pharmaceutical Ingredients (APIs) market. The focus on strengthening in-house API manufacturing will open promising avenues, recent trends in the active pharmaceutical ingredient (API) market indicate. The active pharmaceutical ingredients (API) market size is expected to reach US$331.3 billion by 2031.

Growing investment for the development of biopharmaceuticals is enriching the outlook for the global Active Pharmaceutical Ingredients (APIs) market. The focus on the safety and efficacy of small molecule drugs has opened up an incredible valuation opportunity for companies in the market. Indeed, the increase in the number of product approvals in the segment has generated vast streams of profits for the market players. Pediatric formulations, in particular, fall under the intense jurisdiction of regulators in major regional markets.

Get an exclusive sample PDF copy of Active Pharmaceutical Ingredients (API) Market https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

Key Findings of the Active Pharmaceutical Ingredients (API) Market Research

  • Need for effective drugs for cardiovascular and chronic diseases, propelling revenue growth: The increase in the incidence and burden of cardiovascular diseases and the range of chronic diseases, in particular diabetes, has stimulated the search for new drug candidates. Biopharmaceutical companies profit from the commercialization of targeted therapies. Cardiovascular diseases accounted for a large share of the market in 2020. The increase in the elderly population suffering from these diseases is driving the demand for drugs to manage the diseases, thereby increasing the size of the Active Pharmaceutical Ingredients (APIs) market.
  • Small-molecule cancer drugs show value-gRab opportunity: The rapidly growing adoption of small molecule drugs among pharmaceutical and biopharmaceutical companies has generated tremendous revenue streams. Small molecule drugs accounted for a major market share in 2020, the TMR study found. A number of expiring blockbuster drugs have fueled the outlook for the Active Pharmaceutical Ingredients (APIs) market. This has spurred the development of generics, particularly to target patients in low- and middle-income countries.

Ask for references – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1690

Active Pharmaceutical Ingredients (APIs) Market: Key Drivers

  • The growing demand for branded or innovative prescription drugs for chronic disease management is a key driver for the expansion of the Active Pharmaceutical Ingredients (APIs) market.
  • The prevalence of cardiovascular diseases and the increasing incidence of cancer have imposed a considerable economic and health burden. The need for new drugs to address concerns is propelling R&D into the Active Pharmaceutical Ingredient (API) market.
  • Advances in regulation relating to the safety and efficacy of APIs play a pivotal role in the evolution of the Active Pharmaceutical Ingredients (APIs) market.

Active Pharmaceutical Ingredients (APIs) Market: Regional Growth Momentum

  • Asia-Pacific is expected to become a remarkably lucrative region in the Active Pharmaceutical Ingredients (API) market. Revenue streams are propelled by increased drug development for biologics and generics. In particular, due to the expiration of patents of blockbuster drugs for chronic diseases, the demand for low-cost generics is expected to gain traction in India and China during the forecast period 2021-2031.
  • North America accounted for a major market share in 2020. The growth is fueled by significant investments made by pharmaceutical and biotechnology companies in synthetic APIs. Additionally, advancements in biological processing used for API synthesis will open up new revenue streams in the regional market.

Active Pharmaceutical Ingredients (APIs) Market: Key Players

Key Players of Active Pharmaceutical Ingredients (APIs) Market include GlaxoSmithKline plc., Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AbbVie, Inc., Hisun USA, Inc., Lonza, Novartis AG , Pfizer, Inc., Mylan NV, Sanofi, Merck & Co. and Piramal Pharma Solutions.

Inquire Before You Buy – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1690

Global Active Pharmaceutical Ingredients (APIs) Market: Segmentation

  • Active Pharmaceutical Ingredients (APIs) Market, By Manufacturing Type
    • In-house manufacturing
    • Contract Manufacturing
  • Active Pharmaceutical Ingredients (APIs) Market, By Drug Type
    • Branded or innovative prescription drugs
    • Generic prescription drugs
    • Over-the-counter (OTC) drugs
  • Active Pharmaceutical Ingredients (APIs) Market, By API Type
    • Synthetic
    • Organic
    • Plant extracts
  • Active Pharmaceutical Ingredients (APIs) Market, By Application
    • Anti-infectives
    • Cardiovascular
    • neurological
    • Metabolic disorder
    • Respiratory
    • Oncology
    • Others
  • Active Pharmaceutical Ingredients (APIs) Market, By End User
    • Pharmaceutical and biotechnology industry
    • CRO
    • CMO
    • Others
  • Active Pharmaceutical Ingredients (APIs) Market, By Region
    • North America
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia and New Zealand
      • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of the Middle East and Africa

Modernization of healthcare in terms of infrastructure and services has pushed the healthcare industry to new heights, stay updated with Last Health Care Research Reports by Transparency Market Research:

Ophthalmic Drugs Market: The ophthalmic drugs market is expected to reach US$50.2 billion by the end of 2031 at a CAGR of 6.83% from 2022 to 2031.

Homeopathic Products Market: The global homeopathic products market is expected to reach over US$32.4 billion by the end of 2031 at a CAGR of 11.6% from 2022 to 2031.

Pain Management Therapeutics Market: The global pain management therapeutics market is expected to reach over US$98.0 billion by the end of 2031 at a CAGR of 2.9% from 2022 to 2031 .

Peptide Therapeutics Market: The global peptide therapeutics market is expected to reach over US$91.25 billion by 2031 at a CAGR of 8.8% from 2022 to 2031.

Collagen Peptides and Gelatin Market: The global collagen peptides and gelatin market is expected to reach over US$7.8 billion by the end of 2031 at a CAGR of 5.0% from 2022 to 2031.

Premenstrual Syndrome Treatment Market: The global premenstrual syndrome treatment market is expected to reach over US$1.9 billion by the end of 2031 at a CAGR of 3.4% from 2022 to 2031.

Synthetic Biology Market: The global synthetic biology market is expected to reach over US$74.7 billion by the end of 2031 at a CAGR of 21.3% from 2022 to 2031.

Atipamezole Market: The atipamezole market is expected to grow at a CAGR of 1% during the forecast period 2020-2030.

About Transparency Market Research

Transparency Market Research, a global market research firm registered in Wilmington, Delaware, USA, provides personalized research and advisory services. Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.

For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
HEADQUARTERS IN THE CITY CENTER,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
E-mail: [email protected]